Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Streptozotocin-nicotinamide-induced diabetes in the rat. Characteristics of the experimental model.

Szkudelski T.

Exp Biol Med (Maywood). 2012 May;237(5):481-90. doi: 10.1258/ebm.2012.011372. Epub 2012 May 22. Review.

PMID:
22619373
2.

Metabolic disturbances and defects in insulin secretion in rats with streptozotocin-nicotinamide-induced diabetes.

Szkudelski T, Zywert A, Szkudelska K.

Physiol Res. 2013;62(6):663-70. Epub 2013 Jul 17.

3.

Diabetic characteristics and alveolar bone loss in streptozotocin- and streptozotocin-nicotinamide-treated rats with periodontitis.

Kim JH, Lee DE, Choi SH, Cha JH, Bak EJ, Yoo YJ.

J Periodontal Res. 2014 Dec;49(6):792-800. doi: 10.1111/jre.12165. Epub 2014 Feb 3.

PMID:
24490978
4.

Protective effects of a nicotinamide derivative, isonicotinamide, against streptozotocin-induced β-cell damage and diabetes in mice.

Fukaya M, Tamura Y, Chiba Y, Tanioka T, Mao J, Inoue Y, Yamada M, Waeber C, Ido-Kitamura Y, Kitamura T, Kaneki M.

Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):92-8. doi: 10.1016/j.bbrc.2013.11.024. Epub 2013 Nov 15.

5.
6.
7.
9.
10.

Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.

Kuchmerovska T, Shymanskyy I, Donchenko G, Kuchmerovskyy M, Pakirbaieva L, Klimenko A.

J Diabetes Complications. 2004 Jul-Aug;18(4):198-204.

PMID:
15207836
11.

Nicorandil improves diabetes and rat islet beta-cell damage induced by streptozotocin in vivo and in vitro.

Kasono K, Yasu T, Kakehashi A, Kinoshita N, Tamemoto H, Namai K, Ohno R, Ueba H, Kuroki M, Ishikawa S, Kawakami M.

Eur J Endocrinol. 2004 Aug;151(2):277-85.

12.
13.

[Influence of poly(ADP-ribose) polymerase inhibitors on some parameters of oxidative stress in blood leukocytes of rats with experimental diabetes].

Huzyk MM, Diakun KO, Ianits'ka LV, Kuchmerovs'ka TM.

Ukr Biokhim Zh (1999). 2013 Jan-Feb;85(1):62-70. Ukrainian.

PMID:
23534291
14.

Streptozotocin-induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and beta-cell plasticity.

Dufrane D, van Steenberghe M, Guiot Y, Goebbels RM, Saliez A, Gianello P.

Transplantation. 2006 Jan 15;81(1):36-45.

PMID:
16421474
15.

Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.

Nakamura T, Terajima T, Ogata T, Ueno K, Hashimoto N, Ono K, Yano S.

Biol Pharm Bull. 2006 Jun;29(6):1167-74.

16.

KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity.

Xu J, Zhang L, Chou A, Allaby T, Bélanger G, Radziuk J, Jasmin BJ, Miki T, Seino S, Renaud JM.

Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E326-35. Epub 2007 Nov 27.

17.

Poly(ADP-ribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes.

Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Nozaki T, Jishage K, Watanabe T, Sugimoto T, Nakagama H, Ochiya T, Sugimura T.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2301-4.

18.

Parp1 deficient mice are protected from streptozotocin-induced diabetes but not caerulein-induced pancreatitis, independent of the induction of Reg family genes.

Li B, Luo C, Chowdhury S, Gao ZH, Liu JL.

Regul Pept. 2013 Sep 10;186:83-91. doi: 10.1016/j.regpep.2013.07.005. Epub 2013 Aug 13.

PMID:
23954400
19.
20.

Supplemental Content

Support Center